Bt Brands, Inc. shares rise 1.12% premarket after Bio-Techne Corporation announced advancements in spatial biology portfolio.
ByAinvest
Friday, Sep 26, 2025 7:31 am ET1min read
BTBD--
Bt Brands, Inc. rose 1.12% in premarket trading. The company's stock price increase may be attributed to the advancements in its spatial biology portfolio for the RNAscope™ ISH technology and the Lunaphore COMET™, which enable simultaneous RNA and protein detection on the same tissue section. These technologies support spatial multiomic analysis and deeper insights for pathology workflows, highlighting their potential role in clinical utility workflows for lymphoid malignancies and B-cell clonality.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet